Madagascar vs Yemen: Estimated antiretroviral therapy coverage among people living with HIV
Madagascar
24.0%
in 2025
Yemen
34.0%
in 2025
Madagascar rank
139th
Yemen rank
137th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Madagascar
- Yemen
How they compare
Yemen currently reports 34.0% against 24.0% in Madagascar, a difference of 10.0%.
That makes Yemen's figure about 1.4 times Madagascar's.
Across all 26 years both countries report, Yemen has been ahead every year.
Madagascar ranks 139th and Yemen ranks 137th of 143 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Madagascar | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.3% | 1.1% | 0.8% | Yemen |
| 2010s | 2.8% | 15.0% | 12.2% | Yemen |
| 2020s | 14.8% | 28.7% | 13.8% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Madagascar or Yemen?
- Yemen, at 34.0% against 24.0% in Madagascar as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Madagascar and Yemen?
- 10.0%, with Yemen ahead.
- How many years of comparable data are there for Madagascar and Yemen?
- 26 years are reported by both, from 2000 to 2025.
- How do Madagascar and Yemen rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Madagascar ranks 139th and Yemen ranks 137th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.